Copyright: Jacobio Pharmaceuticals Co., Ltd.   Beijing ICP preparation 17065868-1   



Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314




NEW    |

Jacobio Pharmaceuticals Co. Ltd., founded in 2015, is committed to the health development of human beings and the development of original new drugs with independent intellectual property rights in the world. 

JAB-3312, Jacobio’s Second Innovative Drug, has Obtained FDA’s Approval for Clinical Study
Jacobio's Innovative Drug Approved for Phase IIa Clinical Study in Multiple Solid Tumors and Awarded Orphan Drug Designation for the Treatment of Esophageal Cancer by US FDA
Jacobiopharma won the Zhongguancun high tech Enterprises

Senior Management Team

Innovative medicine leader

 About Us

Our vision is to be a leader in innovative drugs, a promoter for new drug developers, and to provide more products and solutions for the health development of humans.